Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
OBJECTIVE: To describe patterns of healthcare resource utilisation and associated costs for patients with advanced melanoma in the United Kingdom (UK), Italy, and France. METHODS: For patients receiving systemic treatment, or supportive care, data describing hospitalisations, hospice care, and outp...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2012
|
| _version_ | 1797057571126771712 |
|---|---|
| author | Johnston, K Levy, A Lorigan, P Maio, M Lebbe, C Middleton, M Testori, A Bédane, C Konto, C Dueymes, A Sbarigia, U van Baardewijk, M |
| author_facet | Johnston, K Levy, A Lorigan, P Maio, M Lebbe, C Middleton, M Testori, A Bédane, C Konto, C Dueymes, A Sbarigia, U van Baardewijk, M |
| author_sort | Johnston, K |
| collection | OXFORD |
| description | OBJECTIVE: To describe patterns of healthcare resource utilisation and associated costs for patients with advanced melanoma in the United Kingdom (UK), Italy, and France. METHODS: For patients receiving systemic treatment, or supportive care, data describing hospitalisations, hospice care, and outpatient visits were retrieved retrospectively from advanced disease diagnosis as part of a multicountry observational study. Costs were estimated by multiplying utilisation level by unit cost. In an exploratory analysis, costs were compared between individuals who died within one year of initiating first-line treatment (short-term survivors) and those with ≥ 1 year follow-up (long-term survivors). RESULTS: Hospitalisation costs were highest in France (€6262 per-person compared with €3225 in the UK and €2486 in Italy), reflecting higher rates of hospitalisation. In contrast, outpatient costs were highest in the UK (€782 per-person, compared with €115 in France and €72 in Italy), reflecting the highest rate and frequency of outpatient visits and the highest cost per visit. Hospitalisation rates were consistently higher during supportive care compared with systemic therapy. Roughly one-third of patients entered clinical trials and were not included in the analysis. In exploratory analysis, total costs were generally higher for long-term survivors, but monthly per-patient costs were generally lower for long-term survivors, consistent with a hypothesis that resource utilisation and costs do not necessarily increase proportionally with extended survival. CONCLUSION: Total costs associated with resource utilisation for advanced melanoma patients varied across countries. Overall cost differences were due to differences in frequency and intensity of utilisation patterns and variation in unit costs of health resources. |
| first_indexed | 2024-03-06T19:38:20Z |
| format | Journal article |
| id | oxford-uuid:1fcb956c-994b-46ef-9361-e0613a98b7e6 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:38:20Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:1fcb956c-994b-46ef-9361-e0613a98b7e62022-03-26T11:24:00ZEconomic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1fcb956c-994b-46ef-9361-e0613a98b7e6EnglishSymplectic Elements at Oxford2012Johnston, KLevy, ALorigan, PMaio, MLebbe, CMiddleton, MTestori, ABédane, CKonto, CDueymes, ASbarigia, Uvan Baardewijk, M OBJECTIVE: To describe patterns of healthcare resource utilisation and associated costs for patients with advanced melanoma in the United Kingdom (UK), Italy, and France. METHODS: For patients receiving systemic treatment, or supportive care, data describing hospitalisations, hospice care, and outpatient visits were retrieved retrospectively from advanced disease diagnosis as part of a multicountry observational study. Costs were estimated by multiplying utilisation level by unit cost. In an exploratory analysis, costs were compared between individuals who died within one year of initiating first-line treatment (short-term survivors) and those with ≥ 1 year follow-up (long-term survivors). RESULTS: Hospitalisation costs were highest in France (€6262 per-person compared with €3225 in the UK and €2486 in Italy), reflecting higher rates of hospitalisation. In contrast, outpatient costs were highest in the UK (€782 per-person, compared with €115 in France and €72 in Italy), reflecting the highest rate and frequency of outpatient visits and the highest cost per visit. Hospitalisation rates were consistently higher during supportive care compared with systemic therapy. Roughly one-third of patients entered clinical trials and were not included in the analysis. In exploratory analysis, total costs were generally higher for long-term survivors, but monthly per-patient costs were generally lower for long-term survivors, consistent with a hypothesis that resource utilisation and costs do not necessarily increase proportionally with extended survival. CONCLUSION: Total costs associated with resource utilisation for advanced melanoma patients varied across countries. Overall cost differences were due to differences in frequency and intensity of utilisation patterns and variation in unit costs of health resources. |
| spellingShingle | Johnston, K Levy, A Lorigan, P Maio, M Lebbe, C Middleton, M Testori, A Bédane, C Konto, C Dueymes, A Sbarigia, U van Baardewijk, M Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). |
| title | Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). |
| title_full | Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). |
| title_fullStr | Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). |
| title_full_unstemmed | Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). |
| title_short | Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). |
| title_sort | economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the united kingdom italy and france results from a retrospective longitudinal survey melody study |
| work_keys_str_mv | AT johnstonk economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT levya economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT loriganp economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT maiom economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT lebbec economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT middletonm economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT testoria economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT bedanec economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT kontoc economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT dueymesa economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT sbarigiau economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy AT vanbaardewijkm economicimpactofhealthcareresourceutilisationpatternsamongpatientsdiagnosedwithadvancedmelanomaintheunitedkingdomitalyandfranceresultsfromaretrospectivelongitudinalsurveymelodystudy |